Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiminy’s is a sustainable pet nutrition company that develops insect-based protein alternatives for the animal health market. The company utilizes crickets and black soldier fly larvae as primary protein sources to create hypoallergenic dog food and treats that are more digestible than traditional animal proteins. By leveraging insect agriculture, Jiminy’s significantly reduces the environmental impact of pet food production, saving millions of gallons of water and acres of land. Their products are formulated to support canine gut health and provide a complete amino acid profile while addressing common food sensitivities. The company’s portfolio includes various kibble recipes, dental chews, and training treats distributed through major retailers and veterinary channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiminy's.